ADVAZULAR

Details for Australian Trade Mark No. 935764 (hide)

Owner Eli Lilly and Company an Indiana corporation

Service Spruson & Ferguson

Various Convention priority claimed: 25 June 2002, United States of America, No. 76/424500 in respect of PHARMACEUTICAL PREPARATIONS, NAMELY PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND PREVENTION OF BLOOD DISORDERS, CANCER/ONCOLOGY, CARDIOVASCULAR DISEASES,

Classes

Class 5 Pharmaceutical preparations, including pharmaceutical preparations for the treatment and prevention of blood disorders, cancer/oncology, cardiovascular diseases, central nervous systems diseases and disorders, dermatological disorders, diabetic neuropathy, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, immunological, bacterial, viral and fungal disorders, infectious diseases, inflammation and inflammatory diseases, musculoskeletal disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, sepsis, urological disorders

Event Publications

9 August 2012 Renewal of Registration/IR

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

935768-XACTI

935763-C.CH@NGE